B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2022-04-01
叢編:Frontiers in Immunology
主題:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
在線閱讀:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍